Purple Biotech Ltd.
Developing cancer therapies to overcome tumor immune evasion and drug resistance.
PPBT | TA
Overview
Corporate Details
- ISIN(s):
- IL0007650166
- LEI:
- Country:
- Israel
- Address:
- Oppenheimer 4, 7670104 Rehovot
- Website:
- https://purple-biotech.com/
- Sector:
- Mining and quarrying
- Industry:
- Mining of non-ferrous metal ores
Description
Purple Biotech Ltd. is a clinical-stage biopharmaceutical company focused on developing first-in-class therapies for the treatment of cancer. The company's core strategy is to create novel treatments that overcome tumor immune evasion and drug resistance, two significant challenges in oncology. By targeting these mechanisms, Purple Biotech aims to provide more effective and durable therapeutic options for cancer patients. Its development pipeline consists of innovative drug candidates progressing through various stages of clinical trials.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| 2025-09-21 10:55 |
Foreign Filer Report
AT THE MARKET OFFERING AGREEMENT
|
English | 704.8 KB | ||
| 2025-09-21 10:55 |
Foreign Filer Report
AT THE MARKET OFFERING AGREEMENT
|
English | 36.6 KB | ||
| 2025-09-21 10:51 |
Prospectus
PROSPECTUS SUPPLEMENT (At-the-Market)
|
English | 471.1 KB | ||
| 2025-09-21 10:51 |
Foreign Filer Report
PROSPECTUS SUPPLEMENT (At-the-Market)
|
English | 36.6 KB | ||
| 2025-09-16 14:31 |
Foreign Filer Report
CORPORATE PRESETATION- SEPTEMBER 2025
|
English | 36.5 MB | ||
| 2025-09-16 14:31 |
Foreign Filer Report
CORPORATE PRESETATION- SEPTEMBER 2025
|
English | 36.7 KB | ||
| 2025-09-10 17:04 |
Legal Proceedings Report
Receives Intention to Grant a European Patent Covering NT219 Combinations with …
|
English | 158.1 KB | ||
| 2025-09-10 17:04 |
Foreign Filer Report
Receives Intention to Grant a European Patent Covering NT219 Combinations with …
|
English | 36.7 KB | ||
| 2025-09-07 11:04 |
Share Issue/Capital Change
Announces Closing of Up To $18 Million Public Offering $6 million upfront with …
|
English | 82.3 KB | ||
| 2025-09-07 11:04 |
Foreign Filer Report
Announces Closing of Up To $18 Million Public Offering $6 million upfront with …
|
English | 36.7 KB | ||
| 2025-09-07 11:01 |
Foreign Filer Report
Documents regarding the warrants
|
English | 638.0 KB | ||
| 2025-09-07 11:01 |
Foreign Filer Report
Documents regarding the warrants
|
English | 36.6 KB | ||
| 2025-09-07 10:57 |
Prospectus
Prospectus regarding offering of 3,055,000 ADSs and together with warrants
|
English | 435.6 KB | ||
| 2025-09-07 10:57 |
Foreign Filer Report
Prospectus regarding offering of 3,055,000 ADSs and together with warrants
|
English | 36.6 KB | ||
| 2025-09-04 18:29 |
Share Issue/Capital Change
Announces Pricing of Up To $18 Million Public Offering
|
English | 148.1 KB |
Automate Your Workflow. Get a real-time feed of all Purple Biotech Ltd. filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
No Financial Data Available
Standardized financial statements for the selected period are not yet available.
Need More History? Access decades of standardized financials for Purple Biotech Ltd. via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
